The Role of hCG in Thawed Embryo Transfer
ConditionInfertility (IVF Patients)
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorFertility Center of Las Vegas
About this trial
This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Female adult expecting to receive transfer of a thawed embryo.
At least one available frozen blastocyst of transferrable quality.
Non-menopausal female with at least one antral follicle.
Use of pre-implantation genetic testing (PGT), embryos derived from donor oocytes and/or donor sperm, a gestational carrier, and history of prior transfer(s) regardless of outcome are allowed.
Disqualifiers
Minors (age<18 years).
Use of embryo(s) frozen at another center.
Patient insistent on transfer of two embryos.
Patient or partner unable to provide informed consent in English.
Trial design
Design model
Parallel
Treatments tested in this trial
HCG injection
Drug5000 IU hCG injection
No intervention
Other interventionNo hCG administered in this group.
Treatment groups
220 Participants
are divided into 2 treatment groupsGroup A: hCG GroupExperimental treatment 1 intervention
Group B: No hCG GroupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Blood pressure
Mean arterial pressure measured in third trimester of pregnancy
Time frame
Third trimester of pregnancySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov